Sensitivity to Antimicrobial Drugs of Pseudomonas Aeruginosa Extreme-Resistant Strains Isolated in the Major Hospitals of Central Kazakhstan
AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODS: The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakh...
Saved in:
Published in | Open access Macedonian journal of medical sciences Vol. 5; no. 1; pp. 6 - 8 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Macedonia
ID Design 2012/DOOEL Skopje
15.03.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1857-9655 1857-9655 |
DOI | 10.3889/oamjms.2017.023 |
Cover
Loading…
Abstract | AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODS: The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits.RESULTS: All identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.CONCLUSION: Thus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin. |
---|---|
AbstractList | The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.
The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits.
All identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.
Thus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin. AIMThe article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODSThe strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits.RESULTSAll identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.CONCLUSIONThus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin. AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs.MATERIAL AND METHODS: The strains were collected during the prospective multicenter study in large multidisciplinary hospitals of Central Kazakhstan. Susceptibility to antimicrobial drugs was carried out by disk method and the serial dilution method with the interpretation of the results according to EUCAST criteria. Detection of carbapenemases gene of VIM, IMP, NDM and GES classes was carried out by PCR method using the commercial kits.RESULTS: All identified carbapenemases were sorted to VIM class and accounted for 63.64%. Resistance to aminoglycoside drugs exceeded 80%. All the strains were susceptible to polymyxin.CONCLUSION: Thus, at the present stage the circulation of P. aeruginosa strains of XDR category continues in major hospitals in Kazakhstan. The strains remain sensitiveness only to polymyxin. |
Author | Azizov, Ilya S. Shambilova, Natalya A. Lavrinenko, Alyona V. Belyaev, Ilya A. Babenko, Dmitry B. Bissenova, Nelya M. |
AuthorAffiliation | 1 Institute of Antimicrobial Hemotherapy, Smolensk, Russia 2 Karaganda State Medical University, National Scientific Medical Center, Karaganda, Kazakhstan |
AuthorAffiliation_xml | – name: 1 Institute of Antimicrobial Hemotherapy, Smolensk, Russia – name: 2 Karaganda State Medical University, National Scientific Medical Center, Karaganda, Kazakhstan |
Author_xml | – sequence: 1 givenname: Ilya S. surname: Azizov fullname: Azizov, Ilya S. – sequence: 2 givenname: Alyona V. surname: Lavrinenko fullname: Lavrinenko, Alyona V. – sequence: 3 givenname: Ilya A. surname: Belyaev fullname: Belyaev, Ilya A. – sequence: 4 givenname: Dmitry B. surname: Babenko fullname: Babenko, Dmitry B. – sequence: 5 givenname: Natalya A. surname: Shambilova fullname: Shambilova, Natalya A. – sequence: 6 givenname: Nelya M. surname: Bissenova fullname: Bissenova, Nelya M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28293307$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1v1DAQhi1URD_omRvykUu2_sCJc0FaLYVWFIEonK3ZeNL1kthb26lofwM_Gi9bqoLEySPP874zmveQ7PngkZAXnM2k1u1JgHE9pplgvJkxIZ-QA65VU7W1UnuP6n1ynNKaMcZVW3MhnpF9oUUrJWsOyM9L9Mlld-PyLc2Bzn12o-tiWDoY6Ns4XSUaevo54WTDGDwkOsfy63xIQE9_5IgjVl8wuZTBZ3qZIzif6HkKA2S01HmaV0g_wjpEehbSxmUYfnsu0Bd4oB_gDr6vtvLn5Glfmnh8_x6Rb-9Ovy7OqotP788X84uqk0zLquMaa9tYzpRSgnfWtl3fSqZqpZkFEFYqUK-ZlMAR1LJrarnsm8ZiacpeySPyZue7mZYj2m63iNlEN0K8NQGc-bvj3cpchRujpGC61cXg1b1BDNcTpmxGlzocBvAYpmS4bhpd4FoU9OXjWQ9D_kRQgJMdUI6eUsT-AeHMbHM2u5zNNmdTci4K9Y-iK0fNLmyXdcN_db8ALSayog |
CitedBy_id | crossref_primary_10_1371_journal_pone_0307784 crossref_primary_10_36488_cmac_2022_3_254_260 |
Cites_doi | 10.1371/journal.pone.0123690 10.1111/j.1365-2885.2005.00666.x 10.1111/j.1469-0691.2011.03570.x 10.1093/clinids/24.Supplement_1.S157 10.2217/17460913.2.5.501 10.1016/S1473-3099(13)70168-3 10.1586/eri.09.108 10.2217/fmb.15.48 10.1128/JCM.38.1.40-43.2000 10.3389/fpubh.2014.00145 10.1111/j.1574-6976.2011.00268.x 10.1111/joim.12342 10.1016/j.jcf.2016.08.005 |
ContentType | Journal Article |
Copyright | Copyright: © 2017 Ilya S. Azizov, Alyona V. Lavrinenko, Ilya A. Belyaev, Dmitry B. Babenko, Natalya A. Shambilova, Nelya M. Bissenova. 2017 |
Copyright_xml | – notice: Copyright: © 2017 Ilya S. Azizov, Alyona V. Lavrinenko, Ilya A. Belyaev, Dmitry B. Babenko, Natalya A. Shambilova, Nelya M. Bissenova. 2017 |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.3889/oamjms.2017.023 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1857-9655 |
EndPage | 8 |
ExternalDocumentID | PMC5320898 28293307 10_3889_oamjms_2017_023 |
Genre | Journal Article |
GroupedDBID | 53G AAYXX ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION C~G DYU HYE IPNFZ KQ8 M48 M~E OK1 PGMZT RIG RPM SLJYH GROUPED_DOAJ NPM 7X8 ABFKT 5PM |
ID | FETCH-LOGICAL-c3083-c18e6d7d1055521cdd9cf93056580daa2d35a54033a1ea5bc763bf77dedaa3f53 |
IEDL.DBID | M48 |
ISSN | 1857-9655 |
IngestDate | Thu Aug 21 18:31:32 EDT 2025 Thu Sep 04 20:02:02 EDT 2025 Thu Jan 02 22:21:46 EST 2025 Tue Jul 01 03:04:23 EDT 2025 Thu Apr 24 23:08:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 1 |
Keywords | Pseudomonas aeruginosa VIM MALDI-TOF carbapenemases gene Antibiotic resistance |
Language | English |
License | http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3083-c18e6d7d1055521cdd9cf93056580daa2d35a54033a1ea5bc763bf77dedaa3f53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3889/oamjms.2017.023 |
PMID | 28293307 |
PQID | 1877853262 |
PQPubID | 23479 |
PageCount | 3 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5320898 proquest_miscellaneous_1877853262 pubmed_primary_28293307 crossref_primary_10_3889_oamjms_2017_023 crossref_citationtrail_10_3889_oamjms_2017_023 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-Mar-15 |
PublicationDateYYYYMMDD | 2017-03-15 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-Mar-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Macedonia |
PublicationPlace_xml | – name: Macedonia – name: Republic of Macedonia |
PublicationTitle | Open access Macedonian journal of medical sciences |
PublicationTitleAlternate | Open Access Maced J Med Sci |
PublicationYear | 2017 |
Publisher | ID Design 2012/DOOEL Skopje |
Publisher_xml | – name: ID Design 2012/DOOEL Skopje |
References | 29139 29145 29144 29143 29142 29153 29138 29149 29148 29147 29146 29141 29152 29140 29151 29150 27651273 - J Cyst Fibros. 2017 Mar;16(2):222-229 21793988 - Clin Microbiol Infect. 2012 Mar;18(3):268-81 8994799 - Clin Infect Dis. 1997 Jan;24 Suppl 1:S157-68 25279369 - Front Public Health. 2014 Sep 16;2:145 26439366 - Future Microbiol. 2015;10(10):1683-706 17927473 - Future Microbiol. 2007 Oct;2(5):501-12 16050814 - J Vet Pharmacol Ther. 2005 Aug;28(4):349-54 23845533 - Lancet Infect Dis. 2013 Oct;13(10):867-76 10618060 - J Clin Microbiol. 2000 Jan;38(1):40-3 20014903 - Expert Rev Anti Infect Ther. 2010 Jan;8(1):71-93 25798828 - PLoS One. 2015 Mar 23;10(3):e0123690 25556628 - J Intern Med. 2015 May;277(5):501-12 21303394 - FEMS Microbiol Rev. 2011 Sep;35(5):736-55 |
References_xml | – ident: 29147 doi: 10.1371/journal.pone.0123690 – ident: 29150 doi: 10.1111/j.1365-2885.2005.00666.x – ident: 29144 doi: 10.1111/j.1469-0691.2011.03570.x – ident: 29148 doi: 10.1093/clinids/24.Supplement_1.S157 – ident: 29151 doi: 10.2217/17460913.2.5.501 – ident: 29153 doi: 10.1016/S1473-3099(13)70168-3 – ident: 29141 doi: 10.1586/eri.09.108 – ident: 29142 doi: 10.2217/fmb.15.48 – ident: 29146 doi: 10.1128/JCM.38.1.40-43.2000 – ident: 29138 doi: 10.3389/fpubh.2014.00145 – ident: 29139 – ident: 29140 – ident: 29143 doi: 10.1111/j.1574-6976.2011.00268.x – ident: 29145 – ident: 29152 doi: 10.1111/joim.12342 – ident: 29149 doi: 10.1016/j.jcf.2016.08.005 – reference: 21793988 - Clin Microbiol Infect. 2012 Mar;18(3):268-81 – reference: 23845533 - Lancet Infect Dis. 2013 Oct;13(10):867-76 – reference: 27651273 - J Cyst Fibros. 2017 Mar;16(2):222-229 – reference: 16050814 - J Vet Pharmacol Ther. 2005 Aug;28(4):349-54 – reference: 26439366 - Future Microbiol. 2015;10(10):1683-706 – reference: 25798828 - PLoS One. 2015 Mar 23;10(3):e0123690 – reference: 21303394 - FEMS Microbiol Rev. 2011 Sep;35(5):736-55 – reference: 10618060 - J Clin Microbiol. 2000 Jan;38(1):40-3 – reference: 8994799 - Clin Infect Dis. 1997 Jan;24 Suppl 1:S157-68 – reference: 25279369 - Front Public Health. 2014 Sep 16;2:145 – reference: 17927473 - Future Microbiol. 2007 Oct;2(5):501-12 – reference: 20014903 - Expert Rev Anti Infect Ther. 2010 Jan;8(1):71-93 – reference: 25556628 - J Intern Med. 2015 May;277(5):501-12 |
SSID | ssj0001596122 |
Score | 2.0093284 |
Snippet | AIM: The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas... The article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas drugs. The... AIMThe article presents the current data on the sensitivity of the main 37 strains of eXtremaly Drugs Resistance (XDR) category to anti-pseudomonas... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 6 |
SubjectTerms | Basic Science |
Title | Sensitivity to Antimicrobial Drugs of Pseudomonas Aeruginosa Extreme-Resistant Strains Isolated in the Major Hospitals of Central Kazakhstan |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28293307 https://www.proquest.com/docview/1877853262 https://pubmed.ncbi.nlm.nih.gov/PMC5320898 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELWglRAXBC0fW2hlJA5csjRxHMcHhFalVQFthSgrlVM0sR2a0nXKJisVfkN_dGeS7MJCkbjGsZP42Z43HucNYy-EslpIVQSpMzaI89DgOhjpQCSAbN9AIXPa7xgfJYeT-P2JPPmVDqjvwPpG147ySU1m58PL7z_e4IR_TR5nmupXFUzPpiS9HaohmqDbbB3NUkKe2Ljn-t0vwxqteRv9JPkjnUjZSf3c1MaqlfqLev55gvI3k3Rwn93ruSQfdeA_YLec32B3xn20fJNdHdPp9C49BG8qPvJNOS1b5SWs9nY2_1rzquAfaze3FQ5HqPnI4dXSVzXw_cuG9g6DT64mjukbftzmk6j5OxyvSFEtLz1H_sjHcFbN-CIDSdtmv2nMP8BP-HZK1R-yycH-573DoM--EBiBvCwwYeoSqyxl0EQbb6zVptDkcch01wJEVkhAvicEhA5kbnClygulrMNCUUjxiK35yrsnjIcQh8ruxhAJiCHWgE45ILUXNiK9uGTAhovezkwvTU5fdJ6hi0LwZB08GcGTITwD9nJZ4aJT5fj3rc8X8GU4cygcAt5V8zoLU6WQrERJNGCPOziXjVF8WeDyN2BqBejlDaTKvVriy9NWnZsybaQ63fqP5z5ld-k16UhbKJ-xtWY2d9vIcZp8B9n9l8lOO4KvAS3wADM |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sensitivity+to+Antimicrobial+Drugs+of+Pseudomonas+Aeruginosa+Extreme-Resistant+Strains+Isolated+in+the+Major+Hospitals+of+Central+Kazakhstan&rft.jtitle=Open+access+Macedonian+journal+of+medical+sciences&rft.au=Azizov%2C+Ilya+S&rft.au=Lavrinenko%2C+Alyona+V&rft.au=Belyaev%2C+Ilya+A&rft.au=Babenko%2C+Dmitry+B&rft.date=2017-03-15&rft.issn=1857-9655&rft.eissn=1857-9655&rft.volume=5&rft.issue=1&rft.spage=6&rft.epage=8&rft_id=info:doi/10.3889%2Foamjms.2017.023&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1857-9655&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1857-9655&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1857-9655&client=summon |